Skip to main content
Equibles

NORTHERN TRUST CORP

Bank

Position in JSPR — Jasper Therapeutics, Inc.

CIK 73124 CHICAGO, IL
Back to JSPR Full portfolio

Position in JSPR

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$17,632
-$12,656 QoQ
Shares Held
41,882
+21.1% QoQ
Ownership
0.126%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 44 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in JSPR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

NORTHERN TRUST CORP holds $7,872,952,300 across 424 Biotechnology names. JSPR ranks #411 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,486,478 $1,235,108,212
2 REGN
Regeneron Pharmaceuticals, Inc.
 916,467 $571,453,829
3 ALNY
Alnylam Pharmaceuticals, Inc.
 886,900 $266,983,504
4 RPRX
Royalty Pharma plc
 4,718,859 $264,586,419
5 RVMD
Revolution Medicines, Inc.
 1,117,110 $209,212,357
6 MRNA
Moderna, Inc.
 2,985,329 $209,062,587
7 INCY
Incyte Corp
 1,761,966 $199,736,460
8 CYTK
Cytokinetics Inc
 1,647,345 $140,337,319

All Filings in JSPR

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $17,632 41,882
2026-03-31 $30,288 34,576
2025-12-31 $63,274 34,576
2025-09-30 $80,710 33,912
2025-06-30 $193,739 34,908
2025-03-31 $443,286 103,090
2024-12-31 $2,231,365 104,367
2024-09-30 $2,011,541 106,940
2024-06-30 $665,087 29,299
2024-03-31 $666,383 22,697
2023-12-31 $122,223 154,909
2023-09-30 $108,436 154,909
2023-06-30 $212,225 154,909
2023-03-31 $281,067 155,286
2022-12-31 $10,365 21,460
2022-09-30 $16,931 21,460
2022-06-30 $41,417 21,460
2022-03-31 $72,025 20,289
2021-12-31 $159,268 20,289